tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Iterum Therapeutics provides business update
PremiumThe FlyIterum Therapeutics provides business update
3M ago
Iterum Therapeutics Faces Nasdaq Listing Compliance Challenge
Premium
Company Announcements
Iterum Therapeutics Faces Nasdaq Listing Compliance Challenge
3M ago
Buy Rating Affirmed for Iterum Therapeutics Amid Strategic Launch of ORLYNVAH and Strong Market Positioning
Premium
Ratings
Buy Rating Affirmed for Iterum Therapeutics Amid Strategic Launch of ORLYNVAH and Strong Market Positioning
3M ago
Iterum Therapeutics’ Earnings Call: Optimism Amid Challenges
PremiumCompany AnnouncementsIterum Therapeutics’ Earnings Call: Optimism Amid Challenges
4M ago
Iterum Therapeutics sees cash runway into 2Q26
Premium
The Fly
Iterum Therapeutics sees cash runway into 2Q26
4M ago
Iterum Therapeutics sees FY26 ORLYNVAH net product sales $5M-$15M
Premium
The Fly
Iterum Therapeutics sees FY26 ORLYNVAH net product sales $5M-$15M
4M ago
Iterum Therapeutics sees cash runway into 2026
PremiumThe FlyIterum Therapeutics sees cash runway into 2026
6M ago
Iterum Therapeutics Faces Shareholder Pushback on Key Proposals
Premium
Company Announcements
Iterum Therapeutics Faces Shareholder Pushback on Key Proposals
6M ago
Iterum Therapeutics Faces Nasdaq Delisting Notice
Premium
Company Announcements
Iterum Therapeutics Faces Nasdaq Delisting Notice
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100